Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)

Clinical trial NCT04634669 · TERMINATED

Trial details

NCT number: NCT04634669
Sponsor: Axsome Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Treatment Resistant Depression Major Depressive Disorder

Start date: 2020-09-23
Primary completion: 2022-02-18
Enrollment: 181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.